J Korean Ophthalmol Soc.
2004 May;45(5):869-874.
Photodynamic Therapy with Verteporfin for Subfoveal Choroidal Neovascularization in Vogt-Koyanagi-Harada Syndrome
- Affiliations
-
- 1Department of Ophthalmology, Seoul National University College of Medicine, Korea. hgonyu@snu.ac.kr
- 2Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Korea.
Abstract
- PURPOSE
We present a case of photodynamic therapy (PDT) with verteporfin for choroidal neovascularization (CNV) complicated by Vogt-Koyanagi-Harada syndrome. METHODS: A 46-year-old male who had bilateral subfoveal CNV complicated by Vogt-Koyanagi-Harada syndrome underwent 3 sessions of PDT with verteporfin in 1 year. RESULTS: After 3 sessions of PDT with verteporfin, maintenance of visual acuity was achieved without any complication as alteration of retinal pigment epithelium and aggravation of intraocular inflammation, but subfoveal fibrosis developed. CONCLUSIONS: PDT with verteporfin is a good treatment method without any complication for the CNV complicated by Vogt-Koyanagi-Harada syndrome, even though multiple sessions were needed.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Vogt-Koyanagi-Harada Syndrome Associated with Psoriasis Vulgaris
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization-Interval and Number of Application of Verteporfin Treatment
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Pathologic Myopia
- Photodynamic Therapy For Recurred Subfoveal Choroidal Neovascularization After Argon-Laser Photocoagulation
- A Case of Vogt-Koyanagi-Harada syndrome presenting initially with recurrent vertigo
